HOME > TOP STORIES
TOP STORIES
-
REGULATORY Panel OK’s Pfizer Vaccine Use in Age 12-Plus, Longer Refrigerator Storage
May 31, 2021
-
ACADEMIA Hematologist Sees No Swelling Costs from 2 New CAR-T Contenders in Japan; Will Competition Drive Down Prices?
May 28, 2021
-
REGULATORY Japan Approves Rinvoq for Psoriasis, More Drugs for Label Expansions
May 28, 2021
-
BUSINESS Takeda Stepping Up Work to Improve Japanese Ecosystem for Rare Diseases
May 27, 2021
-
REGULATORY Govt Mulls New AMED Organ to Lead Strategic Funding for Vaccine Development
May 26, 2021
-
BUSINESS Sawai, Towa Post Domestic Sales Growth in FY2020, but Nichi-Iko Falters on GMP Violations: Jiho Tally
May 26, 2021
-
REGULATORY Japan Eyes Pfizer Vaccine Use in Younger People, Longer Refrigerator Storage
May 26, 2021
-
ORGANIZATION JPMA Positive on Use of Clinical Research Data in Submissions, but Wary of Funding Database
May 26, 2021
-
BUSINESS Flawed Stability Tests Found for 31 Choseido-Manufactured Products, Recalls Hit 15
May 25, 2021
-
REGULATORY MHLW Panel Backs Japan’s 1st Oncolytic Virus for Conditional Approval
May 25, 2021
-
BUSINESS Novartis Aims to Become Leader in Japan MS Market with Kesimpta Rollout
May 25, 2021
-
ORGANIZATION Ken Suzuki Likely to Come Back as JPWA Chief after 2 Years
May 25, 2021
-
BUSINESS Japan Ethical Drug Market Contracts 1% in Jan.-Mar.; Keytruda Top-Selling Drug for 8th Quarter Running: IQVIA
May 25, 2021
-
BUSINESS Janssen Seeks Japan Approval for COVID-19 Vaccine
May 24, 2021
-
REGULATORY MOF Panel’s Proposal Urges More Stringent Drug Cost Control, Revisiting of Semi-Automatic Listing
May 24, 2021
-
REGULATORY Biz Improvement Order Issued to 3 Codevelopers over Kobayashi Kako’s Fudged Data
May 24, 2021
-
REGULATORY PMDA Review Report: Flexible Discussions Needed for Eligibility of AstraZeneca Vaccine
May 24, 2021
-
ORGANIZATION JPMA Will Work towards Price Maintenance for On-Patent Medicines: New President
May 24, 2021
-
REGULATORY Japan Approves Moderna and AstraZeneca COVID-19 Vaccines
May 21, 2021
-
REGULATORY AstraZeneca, Moderna COVID-19 Vaccines in Line for Japan Approval on May 21
May 21, 2021
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
